American Regent initiates potassium phosphates injection voluntary recall

According to American Regent, potassium phosphates injection, USP, 15 mM/5 mL Phosphorus; 22 mEq/5 mL Potassium, 5 mL Single Dose Vial, belonging to lot number 48 is being recalled.

Potassium phosphates injection, USP, 3 mM Phosphorus/mL, is indicated as a source of phosphorus, for addition to large volume intravenous fluids to prevent or correct hypophosphatemia in patients with restricted or no oral intake.

It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions

American Regent has requested healthcare facilities not to use the affected vials, and to immediately quarantine any product for return.